Illustrative image – not actual.Elder Pharmaceuticals (EPL) is likely to invest in its research and development (R&D) facility in Navi Mumbai, Maharashtra.
EPL plans to invest Rs 130 crore to develop at least eight-nine products each in the women's healthcare and nutraceuticals segments. In 2010, the R&D facility was upgraded to focus on developing new drug delivery systems.
